Materias dentro de su búsqueda.
Mostrando 21 - 40 Resultados de 110,380 Para Buscar '"Lu'an"', tiempo de consulta: 0.86s Limitar resultados
  1. 21
    “…The monogermanide LuGe is obtained via high‐pressure high‐temperature synthesis (5–15 GPa, 1023–1423 K). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    “Excess” electrons in LuGe
  2. 22
    por Ekström, C
    Publicado 1976
    Enlace del recurso
    Enlace del recurso
    Hyperfine structure of $^{175}$Lu and nuclear electromagnetic moments of the lutetium isotopes $^{161-181}$Lu
  3. 23
    “…As the uptake mechanism remains unknown, this work investigates the salivary gland uptake of [(177)Lu]Lu-PSMA-617 by autoradiography studies on pig salivary gland tissue and on PSMA-overexpressing LNCaP cell membrane pellets. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    [(177)Lu]Lu-PSMA-617 Salivary Gland Uptake Characterized by Quantitative In Vitro Autoradiography
  4. 24
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Tumor uptake in glioblastoma multiforme after IV injection of [(177)Lu]Lu-PSMA-617
  5. 25
    “…In vitro and in vivo experiments were conducted in an AR42J cancer cell model, comparing the antagonist [(177)Lu]Lu-satoreotide tetraxetan with the agonist [(177)Lu]Lu-DOTA-TATE in terms of their binding properties, biodistribution, anti-tumour activity and toxicity. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Comparison of the Anti-Tumour Activity of the Somatostatin Receptor (SST) Antagonist [(177)Lu]Lu-Satoreotide Tetraxetan and the Agonist [(177)Lu]Lu-DOTA-TATE in Mice Bearing AR42J SST(2)-Positive Tumours
  6. 26
    “…The radionuclide therapy [(177)Lu]Lu-PSMA-617 was recently FDA-approved for treatment of metastatic castration-resistant prostate cancer. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Characterization of Non-Specific Uptake and Retention Mechanisms of [(177)Lu]Lu-PSMA-617 in the Salivary Glands
  7. 27
    “…BACKGROUND: (177)Lu-radiopharmaceuticals can contain the metastable impurity [(177m)Lu]lutetium with a physical half-life of 160.4 days, in varying concentrations depending on the route of production of the radionuclidic precursor [(177)Lu]lutetium. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Evaluation of the (177m)Lu-concentration in in-house produced (177)Lu-radiopharmaceuticals and commercially available Lutathera(®)
  8. 28
    “…Patients were treated with [(90)Y]Y/[(177)Lu]Lu-DOTATATE (1 : 1) with mixed amino acid infusion for kidney protection. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The Safety and Efficacy of the Repeated PRRT with [(90)Y]Y/[(177)Lu]Lu-DOTATATE in Patients with NET
  9. 29
    por Suryanarayana, M. V.
    Publicado 2021
    “…The simplified system requirements for the photoionization scheme combined with a high production rate of (176)Lu than previously reported is expected to reduce the global shortage of (176)Lu isotope for medical applications.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Isotope separation of (176)Lu a precursor to (177)Lu medical isotope using broadband lasers
  10. 30
    “…METHODS: Whole-body planar images and SPECT/CT images were acquired from 24 patients and 65 cycles at 24h, 48h, and ≥96h after administration of a mean activity of 6.4 GBq [(177)Lu]Lu-PSMA-617 (range 3–10.9 GBq). Dosimetry was performed by use of the following approaches: 2D planar-based dosimetry, 3D SPECT/CT-based dosimetry, and hybrid dosimetry combining 2D and 3D data. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Comparison of different methods for post-therapeutic dosimetry in [(177)Lu]Lu-PSMA-617 radioligand therapy
  11. 31
    “…Our objective was to provide data on the side effect profile of PSMA-directed RLT using the therapeutic radiotracer [(177)Lu]Lu-PSMA I&T. We evaluated patients with castration-resistant metastatic prostate cancer treated with at least three cycles of [(177)Lu]Lu-PSMA I&T. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Hematotoxicity and Nephrotoxicity in Prostate Cancer Patients Undergoing Radioligand Therapy with [(177)Lu]Lu-PSMA I&T
  12. 32
    “…The standard procedure was to give four courses of [(177)Lu]Lu-DOTA-TATE alone, or tandem therapy—[(177)Lu]Lu-DOTA-TATE and [(90)Y]Y-DOTA-TATE. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Epidemiology of Neuroendocrine Neoplasms and Results of Their Treatment with [(177)Lu]Lu-DOTA-TATE or [(177)Lu]Lu-DOTA-TATE and [(90)Y]Y-DOTA-TATE—A Six-Year Experience in High-Reference Polish Neuroendocrine Neoplasm Center
  13. 33
    “…LuAG:Ce, Lu$_{2}$$_{-}$$_{x}$GdTb$_{x}$AG:Ce and Lu$_{3}$$_{-}$ $_{x}$Tb$_{x}$AG:Ce SCFs at x = 0.15–2.285 were prepared by LPE method onto LuAG:Pr substrates and investigated. …”
    Enlace del recurso
    Enlace del recurso
    Alpha and gamma spectroscopy of composite scintillators based on the LuAG:Pr crystals and single crystalline films of LuAG:Ce and (Lu,Gd,Tb)AG:Ce garnets
  14. 34
    por Langenbruch, Christoph Michael
    Publicado 2018
    Enlace del recurso
    LHCb physics: RD + LFV/LU
  15. 35
    por Lu, Miaoran
    Publicado 2019
    Enlace del recurso
    Miaoran Lu - CLHCP2018 - talk
  16. 36
    Enlace del recurso
    LuAlO$_{3}$ : Ce
  17. 37
    Enlace del recurso
    Enlace del recurso
    Linac LU-20 as Injector of Nuclotron
  18. 38
    por Rastikerdar, S, Garrett, C, Gelletly, W
    Publicado 1981
    “…Neutron-deficient isotopes of Lu with masses 158, and 160-5 have been produced in /sup 155/Gd(/sup 14/N, xn) and /sup 151/Eu(/sup 16/O, xn) reactions with beams of /sup 14/N and /sup 16/O from the Manchester HILAC. …”
    Enlace del recurso
    Enlace del recurso
    The decay of neutron-deficient Lu isotopes
  19. 39
    Publicado 2016
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Speaker 2: Lin Lu, China
  20. 40
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    In memory of Prof. Lu Shibi, MD
Herramientas de búsqueda: RSS